Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.160
-0.030 (-2.52%)
At close: Oct 30, 2026, 4:00 PM EDT
1.180
+0.020 (1.72%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Palisade Bio Employees
Palisade Bio had 14 employees as of December 31, 2025. The number of employees increased by 6 or 75.00% compared to the previous year. That makes Palisade Bio the 39,502nd largest employer in the world and 5,836th in the United States.
Employees
14
Change (1Y)
6
Growth (1Y)
75.00%
Revenue / Employee
$35,714
Profits / Employee
-$2,281,500
Market Cap
202.15M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 14 | 6 | 75.00% |
| Dec 31, 2024 | 8 | -1 | -11.11% |
| Dec 31, 2023 | 9 | -3 | -25.00% |
| Dec 31, 2022 | 12 | -1 | -7.69% |
| Dec 31, 2021 | 13 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| ProQR Therapeutics | 187 |
| Artiva Biotherapeutics | 115 |
| BridgeBio Oncology Therapeutics | 88 |
| Cartesian Therapeutics | 75 |
| Compugen | 75 |
| Upstream Bio | 75 |
| Alpha Cognition | 71 |
PALI News
- 3 days ago - Palisade Bio doses first patient in ASCENTRA-UC trial - TheFly
- 3 days ago - Palisade Bio Announces First Patient Dosed in Global Phase 2b ASCENTRA-UC Study Evaluating Once-Daily Oral PALI-2108 for the Treatment of Ulcerative Colitis - GlobeNewsWire
- 11 days ago - Palisade Bio presents clinical, translational findings at UEG - TheFly
- 11 days ago - Palisade Bio Presents Rapid Endoscopic Improvement and New Translational Evidence for PALI-2108 in Inflammatory Bowel Disease at UEG Week 2026 - GlobeNewsWire
- 23 days ago - Palisade Bio initiated with an Outperform at Raymond James - TheFly
- 4 weeks ago - Palisade Bio to present clinical, translational data for PALI-2108 at UEG Week - TheFly
- 4 weeks ago - Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn's Disease at UEG Week 2026 - GlobeNewsWire
- 5 weeks ago - Palisade Bio Transcript: Stifel 2026 Virtual Immunology and Inflammation Forum - Transcripts